Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CRSP
Stock Latest News
The Fly
Crispr Therapeutics price target raised to $56 from $50 at Bernstein
8d ago
CRSP
Premium
The Fly
FDA Commissioner Marty Makary resigns
9d ago
AZN
BMY
Premium
The Fly
Crispr Therapeutics price target raised to $76 from $74 at Evercore ISI
10d ago
CRSP
Premium
The Fly
Crispr Therapeutics price target raised to $82 from $80 at Citi
14d ago
CRSP
Premium
The Fly
Crispr Therapeutics price target lowered to $83 from $86 at BofA
16d ago
CRSP
Premium
Ratings
CRISPR Therapeutics Retains Buy Rating on Casgevy Momentum and 2026 Pipeline Catalysts Despite Price Target Trim to $83
16d ago
CRSP
Premium
Ratings
CRISPR Therapeutics: Pipeline Expansion and In Vivo CAR-T Platform Support Buy Rating; $80 Price Target Reiterated
16d ago
CRSP
Premium
The Fly
Crispr Therapeutics reports Q1 EPS ($1.28), consensus ($1.23)
17d ago
CRSP
Premium
Ratings
Reaffirming Buy on CRISPR Therapeutics: Conference Engagement and Gene-Editing Leadership Support Attractive Risk‑Reward
1M ago
CRSP
Premium
Market News
Cathie Wood’s ARK Invest Dumps $2.1M Worth of META Shares; Stock Sinks
2M ago
ARKF
ARKK
Premium
Market News
IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Diversification and Growth to Investors
2M ago
BSX
IHE
Premium
The Fly
Crispr Therapeutics price target raised to $110 from $105 at Piper Sandler
2M ago
CRSP
Premium
Company Announcements
Crispr Therapeutics Completes $600 Million Convertible Notes Offering
2M ago
8K
CRSP
Premium
Market News
Cathie Wood Invests Over $10M in CRISPR and PAYP Stocks, Trims Stakes in TER and IONS
2M ago
TEM
TXG
Premium
The Fly
Cathie Wood’s ARK Investment buys 113K shares of Crispr Therapeutics today
2M ago
CRSP
Premium
Market News
CRSP, SOLQ: Cathie Wood’s ARK ‘Buys the Dip’ in CRISPR and Solana Staking ETF
2M ago
TXG
WGS
Premium
Company Announcements
Crispr Therapeutics Upsizes Convertible Notes Offering to $550 Million
2M ago
8K
CRSP
Premium
The Fly
Crispr Therapeutics prices upsized convertible senior notes offering
2M ago
CRSP
Premium
The Fly
Cathie Wood’s ARK Investment buys 281K shares of Crispr Therapeutics today
2M ago
CRSP
Premium
Market News
IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Portfolio Diversification to Investors
2M ago
BSX
IHE
Premium
The Fly
Crispr Therapeutics falls -9.2%
2M ago
CRSP
Premium
The Fly
Midday Fly By: HP Enterprise reports Q1 beat, BioNTech announces new company
2M ago
ABM
CNC
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
